Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
272.05
-3.79 (-1.37%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
3
4
5
6
7
8
9
...
53
54
Next >
Thursday's session: gap up and gap down stock in the S&P500 index
May 08, 2025
Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
Via
Chartmill
2 Unstoppable Dividend Stocks to Buy and Hold Forever
May 08, 2025
Via
The Motley Fool
Topics
Intellectual Property
Exposures
Intellectual Property
What the Options Market Tells Us About Amgen
May 07, 2025
Via
Benzinga
Chinese Biotech BeiGene Stock Falls Despite Strong Brukinsa Sales And Earnings Beat
May 07, 2025
BeiGene posted a surprise Q1 profit and $1.12 billion in revenue, with strong U.S. Brukinsa sales, while reaffirming its 2025 outlook and margin guidance.
Via
Benzinga
Forecasting The Future: 7 Analyst Projections For Amgen
May 07, 2025
Via
Benzinga
Amgen Unusual Options Activity For May 02
May 02, 2025
Via
Benzinga
Earnings Scheduled For May 1, 2025
May 01, 2025
Via
Benzinga
Is the Market Bullish or Bearish on Amgen?
April 23, 2025
Via
Benzinga
Amgen's Better Than Expected Q1 Earnings Take Backseat As Eyes Are On MariTide Obesity Data
May 02, 2025
Analysts highlight MariTide's upcoming updates and near-term catalysts, while Amgen's price targets shift amid steady outlook and investor caution.
Via
Benzinga
Nasdaq 100 Leads Wall Street Rally As China Signals Openness To Fentanyl Talks, Easing Trade Tensions
May 02, 2025
U.S. stocks rose on hopes of China's willingness to negotiate a trade deal regarding fentanyl production. Tech stocks led the rally.
Via
Benzinga
Wall Street Eyes 9th Straight Day Of Gains, Apple Falls As Chinese Sales Disappoint: What's Driving Markets Friday?
May 02, 2025
U.S. stocks advanced across the board by midday Friday, with the S&P 500 eyeing its ninth consecutive day of gains—poised for the longest winning streak since May 2024.
Via
Benzinga
3 Biotech Giants Gaining From U.S. Sales and Policy Shifts
May 02, 2025
The significant domestic revenue base of select US biotech companies offers stability potential for investors navigating global trade complexities.
Via
MarketBeat
Topics
Economy
World Trade
Exposures
COVID-19
Supply Chain
Tariff
Amgen’s (NASDAQ:AMGN) Q1: Beats On Revenue
May 01, 2025
Biotech company Amgen (NASDAQ:AMGN) announced better-than-expected revenue in Q1 CY2025, with sales up 9.4% year on year to $8.15 billion. The company expects the full year’s revenue to be around $35...
Via
StockStory
Beat the Nasdaq With This Cash-Gushing Dividend Stock
May 01, 2025
Via
The Motley Fool
Topics
Economy
Stocks
Exposures
Economy
US Equities
Looking At Amgen's Recent Unusual Options Activity
April 30, 2025
Via
Benzinga
Wall Street Eyes 8th Positive Day As S&P 500 Recoups Tariff-Led Losses, Bitcoin Rallies To $97,000: What's Driving Markets Thursday?
May 01, 2025
Wall Street pushed higher in midday trading, with the S&P 500 on track for its eighth consecutive gain — its longest winning streak since November 2023. The index rose about 1% to 5,560, fully...
Via
Benzinga
Topics
Government
Stocks
World Trade
Exposures
Political
Tariff
US Equities
These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount
April 30, 2025
Via
The Motley Fool
Amgen (AMGN) Reports Earnings Tomorrow: What To Expect
April 30, 2025
Biotech company Amgen (NASDAQ:AMGN) will be reporting earnings tomorrow afternoon. Here’s what to expect.
Via
StockStory
Topics
Artificial Intelligence
Economy
World Trade
Exposures
Artificial Intelligence
Economy
Tariff
Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom
April 28, 2025
Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising...
Via
Talk Markets
Topics
ETFs
Stocks / Equities
The Week Ahead: PCE Inflation Data And Big Tech Earnings In Focus
April 27, 2025
Markets brace for crucial week with Big Tech earnings, Trump's 100-day milestone, and key economic data as trade concerns linger.
Via
Talk Markets
Topics
Economy
Government
Stocks / Equities
Exposures
Interest Rates
Political
4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off
April 26, 2025
Via
The Motley Fool
Topics
Economy
Intellectual Property
World Trade
Exposures
Economy
Intellectual Property
Tariff
1 Value Stock to Research Further and 2 to Ignore
April 24, 2025
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are...
Via
StockStory
3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold
April 22, 2025
Via
The Motley Fool
Topics
Government
Exposures
Political
Amgen, Franco-Nevada, Take-Two Interactive And More: CNBC's 'Final Trades'
April 22, 2025
Via
Benzinga
Short Week Finishes With Netflix Q1 Beat
April 18, 2025
Considering the blue-chip Dow face-planted ahead of the open on a disappointing Q1 report from UnitedHealth, which resulted in a -22% tanking by Thursday’s close, this was a pretty flat day.
Via
Talk Markets
Topics
Stocks
Stocks / Equities
Exposures
US Equities
Eli Lilly Rallies Over 14%, Notches Best Day Since June 2000 On Oral Weight-Loss Drug Results: Analysts React
April 17, 2025
Lilly's weight-loss drug trial shows promising results, propelling stock up 14.36%. Goldman Sachs predicts potential $23.5B in sales by 2035.
Via
Benzinga
2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever
April 17, 2025
Via
The Motley Fool
Topics
Government
World Trade
Exposures
Political
Tariff
Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks
April 16, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with AbbVie...
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Sandoz Files Lawsuit Alleging Amgen Illegally Blocked Biosimilar Competition For Its Blockbuster Arthritis Drug
April 14, 2025
Sandoz sues Amgen in U.S. court over Enbrel patents, alleging efforts to block biosimilar Erelzi and delay competition in the inflammatory disease market.
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
Sandoz Files Antitrust Lawsuit Against Amgen Over Inflammation Drug, Seeks Damages: Retail Sentiment Falters
April 14, 2025
Sandoz is seeking an injunction to prevent Amgen from using patent rights to block biosimilar competition and allow Sandoz to launch its Erelzi “as soon as possible.”
Via
Stocktwits
Topics
Government
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
< Previous
1
2
3
4
5
6
7
8
9
...
53
54
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.